Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

1-Phenylpiperazine

Base Information
  • Chemical Name:1-Phenylpiperazine
  • CAS No.:92-54-6
  • Deprecated CAS:123317-04-4
  • Molecular Formula:C10H14N2
  • Molecular Weight:162.235
  • Hs Code.:29335995
  • European Community (EC) Number:202-165-6
  • UNII:J9225CBI7D
  • DSSTox Substance ID:DTXSID8057855
  • Nikkaji Number:J35.451A
  • Wikipedia:Phenylpiperazine
  • Wikidata:Q4862383
  • ChEMBL ID:CHEMBL9434
  • Mol file:92-54-6.mol
1-Phenylpiperazine

Synonyms:1-phenylpiperazine;N-phenylpiperazine;phenylpiperazine;phenylpiperazine dihydrobromide;phenylpiperazine dihydrochloride;phenylpiperazine hydrochloride;phenylpiperazine monohydrochloride

 This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Chemical Property of 1-Phenylpiperazine
Chemical Property:
  • Appearance/Colour:clear colorless to yellow liquid 
  • Vapor Pressure:0.00252mmHg at 25°C 
  • Melting Point:18.8 °C 
  • Refractive Index:1.588 
  • Boiling Point:287.2 °C at 760 mmHg 
  • PKA:pK1:8.71(+1) (25°C,μ=0.1) 
  • Flash Point:138.3 °C 
  • PSA:15.27000 
  • Density:1.028 g/cm3 
  • LogP:1.49000 
  • Storage Temp.:Store in dark! 
  • Solubility.:Insoluble 
  • Water Solubility.:Insoluble 
  • XLogP3:1.1
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:2
  • Rotatable Bond Count:1
  • Exact Mass:162.115698455
  • Heavy Atom Count:12
  • Complexity:124
Purity/Quality:
Safty Information:
  • Pictogram(s): ToxicT, Corrosive
  • Hazard Codes:T,C 
  • Statements: 22-24-34-36/37/38-23/24/25 
  • Safety Statements: 26-36/37/39-45-28A 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Canonical SMILES:C1CN(CCN1)C2=CC=CC=C2
Technology Process of 1-Phenylpiperazine

There total 49 articles about 1-Phenylpiperazine which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With diphenylphosphane; potassium hydroxide; In dimethyl sulfoxide; at 90 ℃; for 1h; Sealed tube; Inert atmosphere;
Guidance literature:
With sodium hydroxide; In water; for 0.166667h;
Guidance literature:
4-phenyl-piperazine-1-carboxylic acid tert-butyl ester; With trifluoroacetic acid; In dichloromethane; at 30 ℃; for 1h;
With sodium hydroxide; In dichloromethane; water; pH=9;
Refernces

Synthesis of 4-(4-iodophenyl)piperazine and the 1-carboxamidino derivative

10.1002/jhet.5570220112

The research aimed to develop new organ-specific radiopharmaceuticals by synthesizing compounds containing the 4-phenylpiperazine moiety, which is known for its selective mechanisms of action and ability to undergo electrophilic substitution reactions. The study successfully synthesized 4(4-iodophenyl)piperazine (2) with a 70% yield and characterized it. This compound was then converted to its 1-carboxamidino derivative (4) with a 61% yield, using S-methylthiouronium sulfate. The researchers chose a milder reaction condition to avoid separation problems and complex mixtures that resulted from higher temperatures. The study concluded that the synthesized compounds could be potential candidates for myocardial imaging radiopharmaceuticals, as the 1-carboxamidino derivative showed identical properties to the radioiodinated material previously evaluated for this purpose. Key chemicals used in the research included 4-phenylpiperazine, iodine monochloride, S-methylthiouronium sulfate, and various solvents such as acetic acid-water mixture and dimethyl sulfoxide.

Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. II. Optimization of the phenylpiperazine moiety of 1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-phenylpiperazinyl-1-trans-propenes.

10.1248/cpb.50.453

The study focuses on the synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives, which were identified as potential antiproliferative agents. These compounds were designed to increase antitumor activity while reducing side effects associated with muscle relaxation and decreased body temperature. The research involved the structural modification of a specific chemical scaffold, particularly the phenylpiperazine moiety, by introducing substituents on the phenyl ring and replacing the phenylpiperazinyl group with piperidinyl groups. The chemicals used in the study included various aniline derivatives, piperazines, and pyrazole derivatives, as well as reagents for synthetic procedures such as bis(2-chloroethyl)amine hydrochloride, p-toluenesulfonic acid, sodium borohydride, and osmium tetraoxide. These chemicals served the purpose of constructing and modifying the target pyrimidinyl pyrazole derivatives to evaluate their in vitro cytotoxic activity against human lung cancer cell lines and their in vivo antitumor activity in murine tumor models. The study aimed to optimize the structure-activity relationship of these derivatives to enhance their efficacy as antitumor agents without causing significant side effects.